‘Response: Early‐stage Hodgkin lymphoma’ by M. Hudson

Publisher： John Wiley & Sons Inc

E-ISSN： 1545-5017|62|1|182-182

ISSN： 1545-5009

Source： PEDIATRIC BLOOD & CANCER (ELECTRONIC), Vol.62, Iss.1, 2015-01, pp. : 182-182

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Trends in the treatment of early‐stage Hodgkin lymphoma

By  

CA: A CANCER JOURNAL FOR CLINICIANS, Vol. 65, Iss. 4, 2015-07 ,pp. : 253-254

John Wiley & Sons Inc

Access to resources Recommend Favorite

Meta-Analyses of Early-Stage Hodgkin Lymphoma

By  

Acta Haematologica, Vol. 125, Iss. 1-2, 2010-12 ,pp. : 32-38

Karger

Access to resources Recommend Favorite

Very low utility of surveillance imaging in early‐stage classic Hodgkin lymphoma treated with a combination of doxorubicin, bleomycin, vinblastine, and dacarbazine and radiation therapy

By  

CANCER, Vol. 121, Iss. 12, 2015-06 ,pp. : 1985-1992

John Wiley & Sons Inc

Access to resources Recommend Favorite

Pre‐treatment neutrophil/lymphocyte ratio and platelet/lymphocyte ratio are prognostic of progression in early stage classical Hodgkin lymphoma

By  

BRITISH JOURNAL OF HAEMATOLOGY, Vol. 180, Iss. 4, 2018-02 ,pp. : 545-549

John Wiley & Sons Inc

Access to resources Recommend Favorite

A phase II trial of RCHOP followed by radioimmunotherapy for early stage (stages I/II) diffuse large B‐cell non‐Hodgkin lymphoma: ECOG3402

By  

BRITISH JOURNAL OF HAEMATOLOGY, Vol. 170, Iss. 5, 2015-09 ,pp. : 679-686

John Wiley & Sons Inc

Access to resources Recommend Favorite